Overview

By the end of this program, the viewer should be able to:

  • Discuss the main role of positron emission tomography/computed tomography (PET/CT) imaging for breast cancer patients. 
  • Discuss the advantages PET imaging offers over conventional imaging. 
  • Discuss the limitation of fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging in general and in breast cancer.

 COURSE LENGTH:  1 Hour
ACCREDITATION TYPE:  ASRT – Category A
CREDIT HOURS:  1

Target Audience

The target audience is breast imagers. Other technologists and medical personnel may also benefit from viewing this program.